Potential of functional MRI as a biomarker in early Alzheimer's disease
about
sameAs
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkersNetwork-based biomarkers in Alzheimer's disease: review and future directionsOptimization of touchscreen-based behavioral paradigms in mice: implications for building a battery of tasks taxing learning and memory functionsAltered memory-related functional connectivity of the anterior and posterior hippocampus in older adults at increased genetic risk for Alzheimer's disease.Structural brain alterations in heart failure: a review of the literature and implications for risk of Alzheimer's disease.Diminished Posterior Precuneus Connectivity with the Default Mode Network Differentiates Normal Aging from Alzheimer's Disease.The functional oculomotor network and saccadic cognitive control in healthy elders.Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's diseaseElevated hippocampal resting-state connectivity underlies deficient neurocognitive function in agingAmyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progressionThe effect of beta-amyloid on face processing in young and old adults: A multivariate analysis of the BOLD signal.Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's diseaseFunctional MRI and neural responses in a rat model of Alzheimer's disease.Brain Activation during Memory Encoding in Type 2 Diabetes Mellitus: A Discordant Twin Pair Study.Use of functional imaging across clinical phases in CNS drug development.Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults.Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.A Hierarchical Feature and Sample Selection Framework and Its Application for Alzheimer's Disease Diagnosis.The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update.Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Cognitive Improvement and Brain Changes after Real-Time Functional MRI Neurofeedback Training in Healthy Elderly and Prodromal Alzheimer's Disease.Neuroimaging and its Relevance to Understanding Pathways Linking Diabetes and Cognitive Dysfunction.Mathematical analysis of the influence of brain metabolism on the BOLD signal in Alzheimer's disease.What is the Relationship of Traumatic Brain Injury to Dementia?The default mode network as a biomarker for monitoring the therapeutic effects of meditation.Early-Onset Alzheimer Disease.Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease.Investigating virtual reality navigation in amnestic mild cognitive impairment using fMRI.Functional Magnetic Resonance Imaging and Functional Near-Infrared Spectroscopy: Insights from Combined Recording Studies.Incident Cerebral Microbleeds Detected by Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.Both hyper- and hypo-activation to cognitive challenge are associated with increased beta-amyloid deposition in healthy aging: A nonlinear effect.Genetics pathway-based imaging approaches in Chinese Han population with Alzheimer's disease risk.Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers.Physical exercise, IGF-1 and cognition A systematic review of experimental studies in the elderly.Differentiation of Alzheimer's disease based on local and global parameters in personalized Virtual Brain modelsHeterogeneity of structural and functional imaging patterns of advanced brain aging revealed via machine learning methodsTest-retest variability of resting-state networks in healthy aging and prodromal Alzheimer's diseaseHead Motion Parameters in fMRI Differ Between Patients with Mild Cognitive Impairment and Alzheimer Disease Versus Elderly Control SubjectsfMRI in Neurodegenerative Diseases: From Scientific Insights to Clinical Applications
P2860
Q26825442-0E408F0A-3535-4292-86F6-52813C4E2B91Q27023864-4EDF077F-169D-4D73-89C9-E67C45735DA2Q28539980-857A9910-041B-443C-B9E4-80A1F36904A0Q30699162-6EB8C298-DFE7-4D37-9151-F37547F2C533Q30937478-FF15E0C7-056C-4917-93F3-629869D71A08Q33575676-D85AEFFE-54FF-4C1E-8A4B-91523ED55637Q33707257-CFEF1AB5-834E-49C0-8345-4CD46CA11AF2Q33745617-38229048-6180-4753-8EC4-DF38CE68988EQ34378779-26E6FC29-BBF0-445E-8278-051EFB12808BQ34709192-338AC248-03BA-4F7D-808F-FD845474C345Q35626520-A7FEE042-4213-486B-85B8-81C8847A126AQ36198910-AA6633D9-5DCC-41B4-982E-FE814CEDC5A1Q36667583-8A70D832-A5CA-4F24-ABB2-D591812DBC05Q36979215-528AE708-2D85-4DB4-9EC4-DD34E6DD3894Q36995060-DA074C22-58B5-4E6A-B014-DC94587F7FDEQ37065259-E07494F0-CD79-42E2-9AD3-32D9FA565ADDQ37698159-D7D9D26D-0327-4772-905E-954E1E726C67Q37721144-43601272-7C38-4B38-B558-037D96BE733DQ37728517-6578A0E0-7525-479E-8AA3-3504745DFB11Q37998086-D04538BA-A293-4EEF-AE5F-D87D5EA0BF3FQ38190687-FADFA0B5-1A6E-4FEB-8B32-DC79907F162DQ38636474-8749A60C-EE87-49FA-86BA-0459137200C6Q38681542-075C0524-F3BF-4D6D-B3A2-6875505DA221Q38921582-07AA9A26-620D-4BF9-AF61-53F3787A7D99Q38922824-865F2957-FD23-4A2C-B9F2-B9CD9FA1C04CQ38992116-3E491864-DD55-4A52-808C-6874D398EDE8Q39243357-5706FDFD-0E51-49A7-8F3B-4155F5309A0BQ39339952-A069481D-805E-4E4C-9EAF-2D88FF5E532FQ40668696-CD9B3055-4AB8-4F07-89E3-8B12C8BEC3B0Q41462750-E0225EFC-4509-4B44-9235-CC1B7D4A8C79Q47192994-E22CB141-CCD8-419F-9A32-543134F84FC5Q47983510-F4A21563-3027-443C-BF8A-B3B9E3AF2175Q48475670-11AAC406-6AB8-498F-98C6-A976D421D82DQ50421378-DF29BB21-F991-4B01-AEE3-275F628C860FQ55514337-238ECF9B-452B-417E-AA89-11FDD3C00F3AQ56967836-BD386D86-85AE-4910-A87E-4F96F0BAF3A3Q57130557-058D13BC-CD2A-4DD6-A9C2-F3FC52FF1627Q57514419-8CB152B8-0703-4C34-85D6-22C922D20049Q57541999-4D602E35-2A0A-4869-B685-FC117BDD2372Q57911678-DCB4B0AD-A41B-4BB4-86EF-5617A7087168
P2860
Potential of functional MRI as a biomarker in early Alzheimer's disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Potential of functional MRI as a biomarker in early Alzheimer's disease
@ast
Potential of functional MRI as a biomarker in early Alzheimer's disease
@en
Potential of functional MRI as a biomarker in early Alzheimer's disease
@nl
type
label
Potential of functional MRI as a biomarker in early Alzheimer's disease
@ast
Potential of functional MRI as a biomarker in early Alzheimer's disease
@en
Potential of functional MRI as a biomarker in early Alzheimer's disease
@nl
prefLabel
Potential of functional MRI as a biomarker in early Alzheimer's disease
@ast
Potential of functional MRI as a biomarker in early Alzheimer's disease
@en
Potential of functional MRI as a biomarker in early Alzheimer's disease
@nl
P2860
P3181
P1476
Potential of functional MRI as a biomarker in early Alzheimer's disease
@en
P2860
P304
P3181
P356
10.1016/J.NEUROBIOLAGING.2011.09.009
P407
P478
32 Suppl 1
P577
2011-12-01T00:00:00Z